Get the Stockscreener App
72.18
0.85%
-0.62
After Hours:
72.10
-0.08
-0.11%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $72.18, with a volume of 5.36M.
It is down -0.85% in the last 24 hours and down -5.26% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$72.80
Open:
$72.74
24h Volume:
5.36M
Relative Volume:
0.63
Market Cap:
$91.83B
Revenue:
$402.11B
Net Income/Loss:
$1.73B
P/E Ratio:
52.17
EPS:
1.3835
Net Cash Flow:
$7.81B
1W Performance:
-1.15%
1M Performance:
-5.26%
6M Performance:
-3.26%
1Y Performance:
+8.57%
1-Day Range:
$71.44
$73.38
1-Week Range:
$70.21
$73.85
52-Week Range:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
72.18 | 92.62B | 402.11B | 1.73B | 7.81B | 1.3835 |
UNH
Unitedhealth Group Inc
|
270.55 | 247.14B | 447.57B | 12.81B | 16.08B | 13.19 |
CI
Cigna Group
|
270.36 | 70.10B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
296.09 | 64.08B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
174.24 | 20.68B | 129.66B | 1.20B | 375.00M | 9.8083 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health Corp. stock slides 1.1% to 72.02 USD on NYSE amid broader S&P 500 pressure - AD HOC NEWS
CVS Caremark nears settlement with FTC as federal regulators target insulin pricing practices - The Business Journals
UBS reiterates CVS Health stock Buy rating after FTC settlement - Investing.com
Provider-insurer contract disputes surge amid denials, downcoding - Modern Healthcare
Mark Cuban Calls $30,000 Corporate Healthcare Burden 'Insane,' Backs Bill To Break Up Big Medicine Giants UNH, CVS, CIUnitedHealth Group (NYSE:UNH) - Benzinga
CVS Health (CVS) Strengthens Market Position Amid Analyst Confidence and Industry Shifts - Insider Monkey
Headquarters of CVS Health Corp in Woonsocket - Reuters Connect
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note - Yahoo! Finance Canada
CVS Reaches Proposed Settlement with FTC, Easing Uncertainty - GuruFocus
FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access - statnews.com
CVS Health stock holds at Outperform as Leerink sees FTC settlement progress - Investing.com
CVS Reaches Proposed Settlement With FTC Over Insulin Pricing - GuruFocus
CVS Nearing FTC Settlement Overlawsuit, JPMorgan Analyst Notes - GuruFocus
CVS reaches insulin pricing settlement with FTC - Reuters
CVS Health MinuteClinic Services Expand Access to Affordable Primary Care Across US in 2026 - AD HOC NEWS
CVS Now Stocking Sonoma Pharmaceuticals' HOCl-Based Burn Relief Hydrogel - GuruFocus
CVS Health's Aetna gives $35K to community orgs in Missouri - Drug Store News
Bernstein Upgrades CVS Health (CVS) Stock to Outperform from Market Perform - Insider Monkey
CVS Stock Quote Price and Forecast - CNN
CVS Health Corp. stock under valuation scrutiny after governance overhaul signals cash flow pressure - AD HOC NEWS
CVS (CVS) director John Gallina granted 582 shares as semi-annual retainer - Stock Titan
CVS Health Corp. Hits Day Low of $71.60 Amid Price Pressure - Markets Mojo
Best Healthcare Stocks to Buy After the Market Pullback - Yahoo Finance
Best Healthcare Stocks to Buy After the Market Pullback - The Motley Fool
CVS Stock Price, Quote & Chart | CVS HEALTH CORP (NYSE:CVS) - ChartMill
John E. Gallina becomes CVS Health (CVS) reporting director on Form 3 - Stock Titan
CVS Health Corp. stock underperforms Thursday when compared to competitors - MarketWatch
CVS Health appoints John E. Gallina to board of directors and audit committee - Investing.com
CVS, Caremark Pocket Money Meant For Rebates, Suit Claims - Law360
CVS Health adds John E. Gallina to board, names him Audit Committee financial expert - TradingView
Former Elevance CFO John Gallina joins CVS Health (CVS) board and audit committee - Stock Titan
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Lawsuit: CVS Caremark inflated drug costs via ‘manipulation scheme’ - InsuranceNewsNet
CVS Declares Consistent Quarterly Dividend Amid Legal Settlement - GuruFocus
CVS Health sets May 4 payout for 66.5-cent quarterly dividend - Stock Titan
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
CVS Health may have violated antitrust laws, Republican lawmakers say - MSN
CVS Health Foundation Invests $2.24 Million to Strengthen Community Health in Charlotte's Historic West End - Finviz
CVS Pharmacy's New AI-Driven Health Screening Expands Access Nationwide Amid Rising Chronic Disease - AD HOC NEWS
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS Remains in Turnaround Mode, Shooting for Ambitious Targets Through 2028 - Morningstar
CVS Health Corporation $CVS Shares Purchased by National Bank of Canada FI - MarketBeat
Moore Capital Management LP Sells 50,000 Shares of CVS Health Corporation $CVS - MarketBeat
Elevation Point Wealth Partners LLC Increases Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Best Health Insurance Stocks for 2026 and How to Invest - The Motley Fool
Iron Triangle Partners LP Has $60.15 Million Stake in CVS Health Corporation $CVS - MarketBeat
KKM Financial LLC Grows Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Stock Holdings Reduced by Holocene Advisors LP - MarketBeat
150,000 Shares in CVS Health Corporation $CVS Acquired by Capitolis Liquid Global Markets LLC - MarketBeat
Chevy Chase Trust Holdings LLC Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.69%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):